Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.94 CAD 0.34% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

Wall Street
Price Targets

CRON Price Targets Summary
Cronos Group Inc

Wall Street analysts forecast CRON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRON is 3.64 CAD with a low forecast of 2.79 CAD and a high forecast of 5.25 CAD.

Lowest
Price Target
2.79 CAD
5% Downside
Average
Price Target
3.64 CAD
24% Upside
Highest
Price Target
5.25 CAD
79% Upside
Cronos Group Inc Competitors:
Price Targets
CONCORDBIO
Concord Biotech Ltd
2% Downside
PPLPHARMA
Piramal Pharma Ltd
2% Downside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
4% Downside
MANKIND
Mankind Pharma Ltd
7% Downside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Cronos Group Inc

The compound annual growth rate of Cronos Group Inc's revenue for the next 3 years is 11%.

N/A
Past Growth
11%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cronos Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
31%
Average Beat

Net Income
Forecast

Net Income Estimate
Cronos Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
53%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRON's stock price target?
Price Target
3.64 CAD

According to Wall Street analysts, the average 1-year price target for CRON is 3.64 CAD with a low forecast of 2.79 CAD and a high forecast of 5.25 CAD.

What is Cronos Group Inc's Revenue forecast?
Projected CAGR
11%

The compound annual growth rate of Cronos Group Inc's revenue for the next 3 years is 11%.

Back to Top